These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 6201562)

  • 1. Rescue of human monoclonal antibody production from an EBV-transformed B cell line by fusion to a human-mouse hybridoma.
    Foung SK; Perkins S; Raubitschek A; Larrick J; Lizak G; Fishwild D; Engleman EG; Grumet FC
    J Immunol Methods; 1984 May; 70(1):83-90. PubMed ID: 6201562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of hybridoma secreting human monoclonal antibody against hepatitis B virus surface antigen.
    Ichimori Y; Harada K; Hitotsumachi S; Tsukamoto K
    Biochem Biophys Res Commun; 1987 Feb; 142(3):805-12. PubMed ID: 3030301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human anti-tetanus toxoid monoclonal antibody secreted by EBV-transformed human B cells fused with murine myeloma.
    Kozbor D; Roder JC; Chang TH; Steplewski Z; Koprowski H
    Hybridoma; 1982; 1(3):323-8. PubMed ID: 6092264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction and testing of mouse--human heteromyelomas for human monoclonal antibody production.
    Teng NN; Lam KS; Calvo Riera F; Kaplan HS
    Proc Natl Acad Sci U S A; 1983 Dec; 80(23):7308-12. PubMed ID: 6316357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Epstein-Barr virus-transformed B cell lines for the generation of immunoglobulin-producing human B cell hybridomas.
    Chiorazzi N; Wasserman RL; Kunkel HG
    J Exp Med; 1982 Sep; 156(3):930-5. PubMed ID: 6286839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The construction and use of a human-mouse myeloma analogue suitable for the routine production of hybridomas secreting human monoclonal antibodies.
    Posner MR; Elboim H; Santos D
    Hybridoma; 1987 Dec; 6(6):611-25. PubMed ID: 3436625
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficient production of stable, human monoclonal antibody-secreting hybridomas from EBV-transformed lymphocytes using the mouse myeloma X63-Ag8.653 as a fusion partner.
    Thompson KM; Hough DW; Maddison PJ; Melamed MD; Hughes-Jones N
    J Immunol Methods; 1986 Nov; 94(1-2):7-12. PubMed ID: 3023493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human monoclonal antibody to purified protein derivative of tuberculin produced by hybrids constructed with Epstein-Barr virus-transformed B lymphocytes and mouse myeloma cells.
    Garzelli C; Puglisi C; Falcone G
    Eur J Immunol; 1986 May; 16(5):584-7. PubMed ID: 3009205
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [A strategy for the production of human monoclonal antibodies].
    Chiba J
    Hum Cell; 1988 Mar; 1(1):31-6. PubMed ID: 2856441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibody to blood group glycosyltransferases, produced by hybrids constructed with Epstein-Barr-virus-transformed B lymphocytes from a patient with ABO-incompatible bone marrow transplant and mouse myeloma cells.
    Kominato Y; Fujikura T; Shimada I; Takizawa H; Hayashi K; Mori T; Matsuda T
    Vox Sang; 1990; 59(2):116-8. PubMed ID: 2173279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of stable Epstein-Barr (EB) virus transformed cell lines and mouse-human hybridomas producing a large quantity of anti-tetanus toxoid (TT) monoclonal antibody.
    Minakawa H; Hirata Y; Sugawara I; Fukuda A; Yoshida TO
    Behring Inst Mitt; 1985 Dec; (78):139-47. PubMed ID: 3008706
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generation of human monoclonal antibodies by fusion of EBV-activated B cells to a human-mouse hybridoma.
    Foung SK; Engleman EG; Grumet FC
    Methods Enzymol; 1986; 121():168-74. PubMed ID: 3014266
    [No Abstract]   [Full Text] [Related]  

  • 13. Human monoclonal antibodies against blood group antigens. Preparation of a series of stable EBV immortalized B clones producing high levels of antibody of different isotypes and specificities.
    Goossens D; Champomier F; Rouger P; Salmon C
    J Immunol Methods; 1987 Aug; 101(2):193-200. PubMed ID: 3039005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production of anti-tumor human monoclonal antibodies using different approaches.
    Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
    Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The hybridization of EBV-immortalized human B-lymphocytes with a human-mouse heteromyeloma cell line.
    Jahn S; Walper A; Grunow R; Heym S; Volk HD; von Baehr R
    Allerg Immunol (Leipz); 1990; 36(4):359-65. PubMed ID: 1965878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human hybridomas constructed with antigen-specific Epstein-Barr virus-transformed cell lines.
    Kozbor D; Lagarde AE; Roder JC
    Proc Natl Acad Sci U S A; 1982 Nov; 79(21):6651-5. PubMed ID: 6292911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human and chimpanzee monoclonal antibodies.
    Van Meel FC; Steenbakkers PG; Oomen JC
    J Immunol Methods; 1985 Jun; 80(2):267-76. PubMed ID: 2989374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of a human hybridoma producing a pure anti-HLA-A2 monoclonal antibody.
    Wallace EF; Foung SK; Bradbury K; Pask SL; Grumet FC
    Hum Immunol; 1990 May; 28(1):65-9. PubMed ID: 2160447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human T cell hybridomas specific for Epstein Barr virus-infected B lymphocytes.
    Lakow E; Tsoukas CD; Vaughan JH; Altman A; Carson DA
    J Immunol; 1983 Jan; 130(1):169-72. PubMed ID: 6292301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An optimized electrofusion-based protocol for generating virus-specific human monoclonal antibodies.
    Yu X; McGraw PA; House FS; Crowe JE
    J Immunol Methods; 2008 Jul; 336(2):142-51. PubMed ID: 18514220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.